Atlantic City Announces Needle Exchange Plans 4/30/04

Drug War Chronicle, recent top items

more...

recent blog posts "In the Trenches" activist feed

SUBSCRIBE TODAY!!!

press release from Drug Policy Alliance, http://www.drugpolicy.org

City Officials in Atlantic City revealed this week that they are planning to establish a sterile syringe access program in the city to prevent the spread of HIV, hepatitis C, and other blood-borne diseases. City officials have long been on record as supporting such a program. The Atlantic City City Council unanimously passed a resolution last year in favor of sterile syringe access. With its commitment to move forward with the establishment of its own program, the city could become the first in the state to have municipally ordained syringe access. City Council President Craig Calloway, who will introduce an ordinance creating the program, said, "If we can save one person's life, in a sense we have saved humanity."

Atlantic City has the highest proportion of African Americans infected with HIV in the state, with 1 in 32 African Americans in the city living with HIV/AIDS, according to the New Jersey Department of Health and Senior Services. Sixty percent of all HIV infections in the city are caused by people sharing dirty needles. Until now, it was thought that municipalities did not have the legal authority to establish their own programs as cities in other states have done. But a legal memo prepared by the Drug Policy Alliance of New Jersey found that the city clearly had such legal authority.

The memo was independently reviewed by the City Solicitor for Atlantic City, who agreed that the city has such legal authority. Roseanne Scotti, Director of the Drug Policy Alliance of New Jersey, applauded the city's move. "We thank the elected officials of Atlantic City for their leadership on this issue," said Scotti. "For too long we have fought the battle against AIDS with one hand tied behind our backs. Nothing the city could do would do more to protect the lives and health of the families and communities in Atlantic City."

New Jersey has the 5th adult HIV rate, the 3rd highest pediatric HIV rate, and the highest percentage of women infected with HIV in the nation. In addition, NJ's rate of injection-related HIV is almost twice the national average. Despite these statistics, New Jersey has been almost alone among states in allowing no access whatsoever to sterile syringes to prevent the spread of HIV, hepatitis C, and other blood-borne diseases. New Jersey is one of only five states that require a prescription to purchase a syringe in a pharmacy, and even in states that require a prescription to purchase a syringe, there are state or municipally mandated syringe access programs. "Anywhere needle exchange has been instituted, it's been successful," South Jersey AIDS Alliance Executive Director Keith Egan said. "There have been reductions in HIV transmission without increases in drug use."

Ronald Cash, Atlantic City's Director of Health and Human Services, has been gathering information from health officials in Philadelphia, which has provided sterile syringe access services since 1991. Cash said, "The numbers are so clear. Needle exchange is a bridge to treatment. It saves money on health care and, most importantly, its saves lives."

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #335, 4/30/04 Announcing: "The New Prohibition: Voices of Dissent Challenge the Drug War" -- New Compendium by Sheriff Masters Features David Borden and Numerous Other Thinkers on Drug Policy | Peruvian Coca Growers' "March of Protest and Sacrifice" Reaches Lima as Government Seeks to Elevate Alternative Leadership | Like a Phoenix from the Ashes: Vancouver's "Pot Block" Rebounds from Weekend Arson Fire | There You Go Again, Joe: CASA Report Uses Suspect Science to Hype Teen Marijuana Menace | NORML 2004: Stroup to Retire, Lobbying the Hill, Initiative Excitement, Medical Marijuana | Newsbrief: Drug Czar, Media Campaign Well-Positioned to Influence November Elections | Newsbrief: FBI Was Looking for Dope, Not Terrorists, 9/11 Commission Says | Atlantic City Announces Needle Exchange Plans | Newsbrief: European Union Blocks Cannabis Exhibition | Newsbrief: New Web Site Compiles Judicial Opposition to Drug War | Newsbrief: Canadian Couple Appalled at Being Treated Like, Well, New Yorkers | Newsbrief: Albuquerque Cops Block 4-20 Event by Closing Park | Newsbrief: Colorado Drug Task Force Sued Over Methamphetamine "Decontamination" Public Stripping | This Week in History | The Reformer's Calendar

This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts

StoptheDrugWar.org: the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]